Category: Markets
Published: 2026-06-30T15:33:35.000Z
The FDA has selected seven pharmaceutical companies, including Eli Lilly and Regeneron, for its PreCheck Pilot Program. This initiative aims to expedite the construction of new manufacturing facilities in the US to strengthen the domestic medicine supply chain. The program involves a two-step process to facilitate early interaction between companies and the FDA, minimizing delays in application approvals and addressing the US's reliance on overseas pharmaceutical manufacturing.
News summary curated and translated by CausifyMarket. Always consult original sources before making any financial decision.